drugset / Trial / NCT02419352
Sugammadex and Cognitive Function
RandomizedParallel-groupDouble-blindScreening
Summary
Post operative cognitive dysfunction (POCD) is recognized as a frequent complication after both cardiac and non cardiac surgery, affecting approximately 1/3 of the patients. The aim of this study is to examine the possible effect of the novel reversal agent sugammadex versus neostigmine/ atropine combination on cognitive function of adult patients after elective surgery during the early post operative period as well as at discharge.
Timeline
- Start
- 2010-09
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atropine | Other / unclassified | — | — |
| Comparator | Neostigmine | Other / unclassified | — | — |
| Comparator | Sugammadex | Other / unclassified | — | — |
Indications
No indication recorded.